跳至主要内容
临床试验/NCT00835874
NCT00835874终止不适用

Probiotic Administartion to Mothers of Preterm Infants to Prevent Necrotizing Enterocolitis and Sepsis

Tel-Aviv Sourasky Medical Center2 个研究点 分布在 1 个国家目标入组 57 人开始时间: 2007年6月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
终止
入组人数
57
试验地点
2
主要终点
all cause mortality at three months of age

研究概览

简要总结

We hypothesize that supplementing maternal diet with probiotics will decrease the incidence of feeding intolerance, necrotizing enterocolitis and sepsis in preterm infants fed breastmilk.

详细描述

Oral probiotics have previously been shown to prevent necrotizing enterocolitis in preterm infants. A few reports of sepsis by a probiotic bacteria have impeded implementation of oral probiotic supplementation in most NICUs. Considering the proven immunomodulatory effect of maternal probiotics on breastfed infants of atopic mothers, we would like to explore the indirect effects of maternal probiotics on preterm infants

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

性别
All
接受健康志愿者

入选标准

  • Mothers of preterm infants
  • Pumping breast milk

排除标准

  • Neonatal congenital anomalies

结局指标

主要结局

all cause mortality at three months of age

时间窗: 3 months

incidence and severity of necrotizing enterocolitis by Bell's staging at Three months

时间窗: 3 months

occurrence of bacterial or fungal infection per blood,csf or urine cultures at three months

时间窗: 3 months

次要结局

  • maternal adverse effects during treatment(3 months)
  • incidence of BPD, PVL, ROP(36 weeks)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验